Anemia is a common complication in patients with chronic kidney disease and those undergoing chemotherapy. CRESP 500 Injection is a trusted treatment used to stimulate red blood cell production and improve hemoglobin levels. At Unnati Pharmax, we specialize in the global export of CRESP 500 from India, ensuring quality-assured medicines with full regulatory compliance.
This blog provides detailed information about CRESP 500 uses, composition, mechanism of action, dosage, side effects, and export availability.
What is CRESP 500 Injection?
CRESP 500 Injection contains Darbepoetin Alfa 500 mcg, a long-acting erythropoiesis-stimulating agent (ESA). It helps the body produce more red blood cells, thereby reducing anemia and the need for blood transfusions.
Because of its extended duration of action, CRESP 500 is widely used in clinical practice.
Uses of CRESP 500 Injection
CRESP 500 is commonly prescribed for:
-
Anemia due to chronic kidney disease (CKD)
-
Chemotherapy-induced anemia
-
Reduction of blood transfusion requirements
-
Management of low hemoglobin levels in cancer patients
Therefore, CRESP 500 plays a crucial role in anemia management.
How Does CRESP 500 Work?
CRESP 500 stimulates the bone marrow to produce red blood cells.
As a result:
-
Hemoglobin levels increase
-
Oxygen delivery to tissues improves
-
Fatigue and weakness reduce
-
Quality of life improves
This makes CRESP 500 an effective supportive care therapy.
Dosage and Administration
-
Administered by subcutaneous or intravenous injection
-
Dosage and frequency depend on patient condition and hemoglobin levels
-
Given under medical supervision
⚠️ Important: Regular monitoring of hemoglobin is required to avoid overcorrection.
Possible Side Effects
Some patients may experience:
-
High blood pressure
-
Headache
-
Joint or muscle pain
-
Injection site reactions
-
Risk of blood clots (rare)
However, with proper monitoring, CRESP 500 is generally well tolerated.
Precautions and Warnings
Patients should inform their doctor if they have:
-
Uncontrolled hypertension
-
History of blood clots
-
Heart disease
-
Seizure disorders
-
Pregnancy or breastfeeding plans
Hemoglobin levels should be monitored regularly during treatment.
Why Choose Unnati Pharmax for CRESP 500 Export?
Unnati Pharmax is a trusted Indian pharmaceutical exporter, serving international healthcare markets with reliability and transparency.
Our Key Advantages
-
WHO-GMP certified manufacturing partners
-
Competitive export pricing
-
Cold-chain and export-grade packaging
-
Complete regulatory documentation
-
Timely worldwide delivery
As a result, global buyers trust Unnati Pharmax for injectable and oncology-support medicines.
Global Export of CRESP 500 Injection
We export CRESP 500 to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Additionally, we assist with regulatory and customs documentation for smooth import clearance.
Frequently Asked Questions (FAQs)
1. What is CRESP 500 used for?
CRESP 500 is used to treat anemia caused by chronic kidney disease and chemotherapy.
2. Is CRESP 500 chemotherapy?
No. CRESP 500 is a supportive care biologic, not chemotherapy.
3. Can CRESP 500 be exported from India?
Yes. Unnati Pharmax exports CRESP 500 with full regulatory compliance.
4. How should CRESP 500 be stored?
Store in a refrigerator at 2–8°C. Do not freeze or shake.
5. Why buy CRESP 500 from Unnati Pharmax?
Because we ensure authentic products, export expertise, cold-chain handling, and reliable global supply.
Conclusion
In conclusion, CRESP 500 Injection is an effective and widely used treatment for anemia in CKD and cancer patients. Choosing a reliable exporter ensures product quality, safety, and uninterrupted availability.
